Literature DB >> 25081374

HOXD10 expression in human breast cancer.

N V Vardhini1, P Jagan Mohan Rao, P Balakrishna Murthy, G Sudhakar.   

Abstract

Breast cancer is the most frequent malignancy among females. In this study, we analyzed the expression pattern of a homeobox gene (HOXD10) in human invasive ductal breast cancer tissues and normal tissues. With the ACTB (β-actin) gene as a reference, HOXD10 was detected in 60 breast cancer tissues by using the quantitative real-time PCR (qPCR) method with the Relative Expression Software Tool (REST). We found that the HOXD10 expression level was significantly different between cancerous and normal tissues. Downregulation of the HOXD10 gene expression was examined in high-grade samples. Low-grade tissue showed no difference from the control group. HOXD10 expression was reduced in grade II breast carcinoma tissues. This data reveal that misexpression of the HOXD10 gene supports the development and involvement in breast cancer and may serve as a potential biomarker for the diagnosis of human ductal invasive breast carcinoma.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25081374     DOI: 10.1007/s13277-014-2324-z

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  27 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  How to do successful gene expression analysis using real-time PCR.

Authors:  Stefaan Derveaux; Jo Vandesompele; Jan Hellemans
Journal:  Methods       Date:  2009-12-05       Impact factor: 3.608

3.  Gene expression profiling predicts clinical outcome of breast cancer.

Authors:  Laura J van 't Veer; Hongyue Dai; Marc J van de Vijver; Yudong D He; Augustinus A M Hart; Mao Mao; Hans L Peterse; Karin van der Kooy; Matthew J Marton; Anke T Witteveen; George J Schreiber; Ron M Kerkhoven; Chris Roberts; Peter S Linsley; René Bernards; Stephen H Friend
Journal:  Nature       Date:  2002-01-31       Impact factor: 49.962

Review 4.  Hox genes in vertebrate development.

Authors:  R Krumlauf
Journal:  Cell       Date:  1994-07-29       Impact factor: 41.582

5.  MicroRNA-10b induces glioma cell invasion by modulating MMP-14 and uPAR expression via HOXD10.

Authors:  Lihua Sun; Wei Yan; Yingyi Wang; Guan Sun; Hui Luo; Junxia Zhang; Xiefeng Wang; Yongping You; Zhengxiang Yang; Ning Liu
Journal:  Brain Res       Date:  2011-03-16       Impact factor: 3.252

6.  A dual role for Hox genes in limb anterior-posterior asymmetry.

Authors:  József Zákány; Marie Kmita; Denis Duboule
Journal:  Science       Date:  2004-06-11       Impact factor: 47.728

7.  Tumour invasion and metastasis initiated by microRNA-10b in breast cancer.

Authors:  Li Ma; Julie Teruya-Feldstein; Robert A Weinberg
Journal:  Nature       Date:  2007-09-26       Impact factor: 49.962

8.  Expression of HOXD10 gene in normal endometrium and endometrial adenocarcinoma.

Authors:  J Osborne; C Hu; C Hawley; L J Underwood; T J O'Brien; V V Baker
Journal:  J Soc Gynecol Investig       Date:  1998 Sep-Oct

9.  Trends in incidence rates of invasive lobular and ductal breast carcinoma.

Authors:  Christopher I Li; Benjamin O Anderson; Janet R Daling; Roger E Moe
Journal:  JAMA       Date:  2003-03-19       Impact factor: 56.272

10.  Aberrant HOXC expression accompanies the malignant phenotype in human prostate.

Authors:  Gary J Miller; Heidi L Miller; Adrie van Bokhoven; James R Lambert; Priya N Werahera; Osvaldo Schirripa; M Scott Lucia; Steven K Nordeen
Journal:  Cancer Res       Date:  2003-09-15       Impact factor: 12.701

View more
  12 in total

1.  Frequent promoter methylation of HOXD10 in endometrial carcinoma and its pathological significance.

Authors:  Fan Yang; Dongchen Liu; Yupeng Deng; Jun Wang; Shuyu Mei; Shuang Ge; Hailing Li; Cuijuan Zhang; Tingguo Zhang
Journal:  Oncol Lett       Date:  2020-03-19       Impact factor: 2.967

2.  HOX genes: potential candidates for the progression of laryngeal squamous cell carcinoma.

Authors:  Rafaela de Barros E Lima Bueno; Anelisa Ramão; Daniel Guariz Pinheiro; Cleidson Padua Alves; Vinicius Kannen; Achim A Jungbluth; Luiza Ferreira de Araújo; Bruna Rodrigues Muys; Aline Simoneti Fonseca; Jessica Rodrigues Plaça; Rodrigo Alexandre Panepucci; Luciano Neder; Fabiano P Saggioro; Rui Celso M Mamede; David Livingstone Alves Figueiredo; Wilson Araújo Silva
Journal:  Tumour Biol       Date:  2016-09-22

3.  Bridging Links between Long Noncoding RNA HOTAIR and HPV Oncoprotein E7 in Cervical Cancer Pathogenesis.

Authors:  Sweta Sharma; Paramita Mandal; Tamal Sadhukhan; Rahul Roy Chowdhury; Nidhu Ranjan Mondal; Biman Chakravarty; Tanmay Chatterjee; Sudipta Roy; Sharmila Sengupta
Journal:  Sci Rep       Date:  2015-07-08       Impact factor: 4.379

4.  Knockdown of UbcH10 enhances the chemosensitivity of dual drug resistant breast cancer cells to epirubicin and docetaxel.

Authors:  Cheng Wang; Yun-Hao Pan; Ming Shan; Ming Xu; Jia-Lin Bao; Li-Ming Zhao
Journal:  Int J Mol Sci       Date:  2015-03-02       Impact factor: 5.923

5.  MicroRNA-376b promotes breast cancer metastasis by targeting Hoxd10 directly.

Authors:  Ning An; Xinmei Luo; Ming Zhang; Ruilian Yu
Journal:  Exp Ther Med       Date:  2016-12-01       Impact factor: 2.447

6.  Long non-coding RNA HOTAIR enhances radioresistance in MDA-MB231 breast cancer cells.

Authors:  Yun Zhou; Chaoqun Wang; Xia Liu; Chengjun Wu; Haitao Yin
Journal:  Oncol Lett       Date:  2017-01-11       Impact factor: 2.967

7.  miR-224 enhances invasion and metastasis by targeting HOXD10 in non-small cell lung cancer cells.

Authors:  Shuang Li; Jingang Zhang; Yunwei Zhao; Fengling Wang; Ying Chen; Xiubin Fei
Journal:  Oncol Lett       Date:  2018-03-12       Impact factor: 2.967

8.  Identification of IDH-mutant gliomas by a prognostic signature according to gene expression profiling.

Authors:  Qiangwei Wang; Zhiliang Wang; Guanzhang Li; Chuanbao Zhang; Zhaoshi Bao; Zheng Wang; Gan You; Tao Jiang
Journal:  Aging (Albany NY)       Date:  2018-08-15       Impact factor: 5.955

9.  HOXD10 acts as a tumor-suppressive factor via inhibition of the RHOC/AKT/MAPK pathway in human cholangiocellular carcinoma.

Authors:  Haixia Yang; Jiupeng Zhou; Jianqiang Mi; Ke Ma; Yangwei Fan; Jing Ning; Chuying Wang; Xin Wei; Huadong Zhao; Enxiao Li
Journal:  Oncol Rep       Date:  2015-08-10       Impact factor: 3.906

10.  Knockdown of LncRNA MAPT-AS1 inhibites proliferation and migration and sensitizes cancer cells to paclitaxel by regulating MAPT expression in ER-negative breast cancers.

Authors:  Yiyuan Pan; Yiqi Pan; Yue Cheng; Fan Yang; Zhihan Yao; Ouchen Wang
Journal:  Cell Biosci       Date:  2018-02-05       Impact factor: 7.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.